Search Results
Signs and Symptoms
In the early stages of myeloma, some patients have no signs or symptoms of the disease. It is sometimes detected before symptoms appear, when results of laboratory tests done as part of a routine medical examination show abnormalities in the blood and/or urine. When symptoms are present, the most common ones are bone pain and fatigue.
Signs of MyelomaDoctors sometimes refer to the acronym, CRAB, to describe signs of myeloma. The letters stand for
Signs and Symptoms
Signs and symptoms vary from patient to patient and depend on the type of CMML. Click here to learn more about subtypes of CMML.
Those with a myelodysplastic subtype (MD-CMML) tend to present with low blood cell counts. Signs and symptoms may include:
Signs and Symptoms
Signs and symptoms are changes in the body that may indicate disease. A sign is a change that the doctor sees during an examination or on a laboratory test result. A symptom is a change that a patient can see and/or feel. A person who has signs or symptoms that suggest the possibility of leukemia is usually referred to a specialist. This is a hematologist-oncologist. A hematologist-oncologist is a doctor who has special training in diagnosing and treating blood cancers such as leukemia, lymphoma and myeloma.
Signs and Symptoms
Essential thrombocythemia (ET) is often detected during a routine blood test before an individual has any symptoms.
The signs and symptoms of ET are linked to high platelet counts that cause the development of a thrombus (blood clot). The symptoms include:
Signs and Symptoms
A person who has signs or symptoms that suggest the possibility of non-Hodgkin lymphoma (NHL) is usually referred to a blood cancer specialist called a hematologist-oncologist. The doctor will order additional tests and a tissue biopsy to make a diagnosis. The signs and symptoms of NHL are also associated with a number of other, less serious diseases.
The most common early sign of NHL is painless swelling of one or more lymph node(s).
Signs and Symptoms
The signs and symptoms of hairy cell leukemia aren't specific and are common to other, less serious illnesses. However, if you're troubled by any of the following symptoms, see your doctor:
Signs and Symptoms
People who have chronic myeloid leukemia (CML) may not have any symptoms at first. Often, patients learn they have CML after a routine physical exam or a blood test. CML signs and symptoms tend to develop gradually. Those with symptoms often report experiencing:
Signs and Symptoms
Signs and symptoms are changes in the body that may indicate the presence of disease. A sign is a change that the doctor sees during an exam or in a laboratory test result. A symptom is a change that a patient can see and/or feel.
It is common for a child with ALL to feel a loss of well-being because of the lack of normal, healthy blood cells.
Symptoms of a low red blood cell count (anemia) include:
Signs and Symptoms
Children who have juvenile myelomonocytic leukemia (JMML) may have the following signs and symptoms:
- Difficulty breathing and/or dry cough
- Enlarged lymph nodes
- Abdominal pain and loss of appetite caused by enlarged kidney, liver and/or spleen
- Bone and joint pain
- Fatigue and pale skin (from low level of red blood cells)
- Easy bruising and bleeding (from low level of platelets)
- Frequent infections (from low level of white blood cells)
Some children also have skin changes which can include
Signs and Symptoms
The most common symptom of Hodgkin lymphoma is one or more enlarged (swollen) lymph nodes. The enlarged lymph node may be in the neck, upper chest, armpit, abdomen or groin. The swollen lymph node is usually painless.
Other signs and symptoms of Hodgkin lymphoma may include
Signs and Symptoms
The signs and symptoms of acute myeloid leukemia (AML) are common to other, less serious illnesses. However, if you're troubled by any of the following symptoms, see your doctor:
It is common for people with AML to feel a loss of well-being because of the underproduction of normal bone marrow cells.
Symptoms of a low red blood cell count (called “anemia”) include:
Signs and Symptoms
Some patients initially have no symptoms of MDS, and abnormal results from routine blood tests may be the earliest signs of the disease. For patients with symptoms, it is common not to feel well because of the lack of normal, healthy blood cells.
Anemia is a decrease in the number of healthy red blood cells. Red blood cells carry oxygen throughout the body. Anemia may cause symptoms such as:
Signs and Symptoms
MF usually develops slowly. MF often does not cause early symptoms and may be found during a routine blood test. When fibrosis develops in the bone marrow, the bone marrow is unable to produce enough normal blood cells. The lack of blood cells causes many of the signs and symptoms of MF. These include:
Signs and Symptoms
It is common for children with AML to feel a loss of well-being because of the underproduction of normal bone marrow cells.
Symptoms of a low red blood cell count (called “anemia”) include the following:
- Fatigue
- Weakness
- Shortness of breath during normal physical activities
- Lightheadedness, dizziness or faintness
- Headaches
- Pale complexion
Symptoms of a low white blood cell count (called “neutropenia”) include the following:
Signs and Symptoms
Polycythemia vera (PV) develops slowly, and it may not cause symptoms for many years. The condition is often diagnosed during a routine blood test before severe symptoms occur.
Symptoms may include:
Signs and Symptoms
Many people are diagnosed with CLL even though they do not have any symptoms. The disease may be suspected because of abnormal results from blood tests that were ordered either as part of an annual physical or a medical examination for an unrelated condition. An unexplained elevated white blood cell (lymphocyte) count is the most common finding that leads a doctor to consider a CLL diagnosis.
Generally, CLL symptoms develop over time. As the disease progresses, a person may experience
Ask the Doctor Part 2: Five Questions about Lymphoma
Lymphoma survivor, Jessica Melore talks to Dr. Nichols about the Latest in Lymphoma Research and Treatment
How Washington’s new law advances clinical trial diversity
Clinical trials are crucial for advancing cancer care. For individual patients, access to trials can be lifesaving. For researchers and doctors, trials help identify better treatments and cures.
But historically, many groups of people face barriers to enrolling in clinical trials. These groups include people of color, younger patients, older patients, and patients living in rural areas.
Cobimetinib
Cobimetinib is indicated as a single agent for the treatment of adult patients with histiocytic neoplasms.
Gemtuzumab ozogamicin
Gemtuzumab ozogamicin is approved for the treatment of
- Newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and pediatric patients 1 month and older
- Relapsed or refractory CD33-positive AML in adults and pediatric patients 2 years and older (1.2).
When the Insurance Says No to a Clinical Trial
As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era.
But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option.
Remembering Cancer with a Tattoo, New Career and Anniversary Party
In Jon Christoffersen’s house, important occasions - such as the end of chemotherapy - are worthy of great celebration. First it was a tattoo to mark the beginning and end of his treatment, and now, on his 10-year anniversary of being cancer free, it’s time to party.
Olutasidenib
Olutasidenib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test.
Eight Years and Counting: "The Gray Zone"
If you want to get technical, I have cancer. At least I think I do. I was diagnosed eight years ago with chronic myeloid leukemia (CML) and while there are no longer any signs of disease in my bone marrow, this is a condition that never really goes away. The cancer-causing enzymes keep firing and my daily Gleevec pills continue pummeling them into submission. I like to think of myself as a cancer survivor, but dare I be so cocky? Not only do I not want to tempt fate, but it feels a bit like I’m staking claim to a territory I’m not fully entitled to.
Working with Lawmakers to Address the Unique Needs of Cancer Patients
As the coronavirus continues its spread, The Leukemia & Lymphoma Society (LLS) has a vital role to play in ensuring our government takes every step necessary to protect cancer patients. With that in mind, we’re sharing with our community what LLS has been doing to make sure the unique needs of blood cancer patients are being heard by the government at this unprecedented time.